Baeyer–Villiger Oxidation of the Bicyclo[2.2.2]octanone System Revisited
FULL PAPER
Baeyer–Villiger Oxidation of the Substrates
tBu), 1.68 (ddd, J = 1.7, 5.2, 15.3 Hz, 1 H, H6), 1.75 (dd, J = 6.1,
15.4 Hz, 1 H, H7Ј), 2.00–2.16 (m, 5 H, H9Ј, H7Ј, H6, H8), 2.30 (ddd,
J = 5.7, 8.6, 16.2 Hz, 1 H, H9Ј), 2.39 (dd, J = 1.5, 18.7 Hz, 1 H,
H4), 2.44 (s, 3 H, TsЈ), 2.45 (s, 3 H, Ts), 2.98 (ddd, J = 1.7, 5.4,
6.6 Hz, 1 H, H5Ј), 3.12 (dd, J = 2.6, 18.7 Hz, 1 H, H4), 3.38–3.44
(m, 2 H, H9, H8Ј), 3.71 (dd, J = 1.2, 11.9 Hz, 1 H, H2Ј), 4.35 (ddd,
J = 1.8, 3.2, 5.6 Hz, 1 H, H1), 4.41 (dd, J = 1.4, 11.9 Hz, 1 H, H2Ј),
4.78–4.87 (m, 2 H, H7, H6Ј), 7.34 (d, J = 8.3 Hz, 4 H, Ts), 7.79 (d,
J = 8.3 Hz, 4 H, Ts) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.2
(MeЈ), 27.4 (Me), 27.7 (2 Ac), 28.7 (6 C, 2 tBu), 32.2 (C9Ј), 35.0
(C5), 37.3 (C8), 38.4 (C7Ј), 38.8 (C6), 39.5 (C1Ј), 43.3 (C4), 46.0
(C5Ј), 68.7 (C8Ј), 69.1 (C9), 73.3 (C2), 73.7 (tBuЈ), 74.0 (tBu), 74.3
(C1), 74.8 (C6Ј), 75.2 (C7), 127.8 (4 C, Ts), 129.9 (4 C, Ts), 133.6
6-(tert-Butyldimethylsilanyloxy)-8-hydroxy-5-methyl-2-oxabicyclo-
[3.3.1]nonan-3-one (30): Starting from 17b (74 mg, 0.314 mmol) and
using the general procedure, 30 (46.5 mg, 49%) was obtained, after
stirring at room temp. for 14 h (silica gel chromatography, heptane/
EtOAc, 1:1), along with impure 31 (5.4 mg, 4%) and recovered
starting material (11 mg, 14.8%). [α]2D0 = 65 (c = 1.0, CHCl3). M.p.
1
188–189 °C (CH2Cl2). H NMR (300 MHz, CDCl3): δ = 0.04 (s, 3
H), 0.06 (s, 3 H), 0.87 (s, 9 H), 0.96 (s, 3 H), 1.29 (ddd, J = 11.6,
11.6, 13.7 Hz, 1 H), 1.46 (ddd, J = 1.7, 2.2, 14.6 Hz, 1 H), 1.94 (dd,
J = 4.6, 14.6 Hz, 1 H), 2.02 (dd, J = 0.9, 19.0 Hz, 1 H), 2.17 (dddd,
J = 1.0, 5.1, 5.1, 13.7 Hz, 1 H), 2.25 (br. s, 1 H), 2.94 (dd, J = 2.4,
19.0 Hz, 1 H), 3.37 (ddd, J = 0.7, 5.1, 11.4 Hz, 1 H), 3.65 (ddd, J
= 2.4, 5.2, 11.9 Hz, 1 H), 4.61 (dddd, J = 1.0, 1.7, 2.4, 4.6 Hz, 1
H) ppm. 13C NMR (75 MHz, CDCl3): δ = –4.8, –3.8, 18.1, 25.9,
26.6, 33.9, 34.8, 36.2, 37.2, 70.6, 73.8, 78.5, 171.6 ppm. IR (film):
1698, 1313, 1249, 1215, 1130, 993, 835, 775 cm–1. ESIMS (MeOH):
m/z (%) = 323.1 (100) [M + Na]+. HRESIMS (MeOH): calcd. for
C15H28O4NaSi 323.1655; found 323.1644. C15H28O4Si (300.46):
calcd. C 59.96, H 9.39; found C 60.04, H 9.46.
(2 C, Ts), 145.1 (2 C, Ts), 171.5 (2 C, C3, C4Ј) ppm. IR (film): ν =
˜
2963, 2927, 2873, 2856, 1782, 1731, 1598, 1365, 1190, 1176,
882 cm–1. ESIMS (MeOH): m/z (%) = 419.1 (100) [M + Na]+.
HRESIMS: calcd. for C20H28O6SNa 419.1504; found 419.1495.
C20H28O6S (396.16): calcd. C 60.58, H 7.12, S 8.09; found C 64.09,
H 8.06, S 5.68.
9-tert-Butoxy-5-methyl-3-oxo-2-oxabicyclo[3.2.2]non-7-yl Acetate
24 and 8-tert-Butoxy-1-methyl-4-oxo-3-oxabicyclo[3.2.2]non-6-yl
Acetate (25): Starting from 11 (43 mg, 0.16 mmol) and using the
general procedure, 24 and 25 (16.6 mg) were obtained as an insepa-
rable mixture, after stirring at room temp. for 4 d in 37% combined
yield and 1:1 ratio (silica gel chromatography, heptane/EtOAc, 10:1
to 3:1), along with recovered starting material 11 (23.2 mg, 54%).
1H NMR (300 MHz, CDCl3): δ = 0.84 (s, 3 H, Me), 0.88 (s, 3 H,
MeЈ), 1.10 (s, 18 H, tBu), 1.68 (dd, J = 5.7, 14.9 Hz, 1 H, H6), 1.75
(dd, J = 5.7, 15.0 Hz, 1 H, H7Ј), 1.85 (ddd, J = 1.4, 5.6, 15.3 Hz,
1 H, H9Ј), 1.92–2.12 (m, 3 H, H8, H7, H7Ј), 1.99 (s, 3 H, Ac), 2.02
(s, 3 H, Ac), 2.17 (ddd, J = 6.9, 8.5, 15.3 Hz, 1 H, H9Ј), 2.27 (ddd,
J = 5.4, 8.6, 16.2 Hz, 1 H, H8), 2.37 (dd, J = 1.4, 18.6 Hz, 1 H,
H4), 3.03 (ddd, J = 1.5, 5.1, 6.9 Hz, 1 H, H5Ј), 3.10 (dd, J = 2.7,
18.6 Hz, 1 H, H4), 3.41 (m, 2 H, H9, H8Ј), 3.64 (dd, J = 1.2,
11.9 Hz, 1 H, H2Ј), 4.41 (dd, J = 1.6, 11.9 Hz, 1 H, H2Ј), 4.44 (ddd,
J = 1.9, 3.5, 5.4 Hz, 1 H, H1), 4.89 (ddd, J = 3.4, 5.7, 9.6 Hz, 1 H,
H7), 4.95 (dt, J = 5.4, 9.2 Hz, 1 H, H6Ј) ppm. 13C NMR (75 MHz,
CDCl3): δ = 21.0 (Ac), 21.1 (Ac), 24.3 (MeЈ), 27.6 (Me), 28.8 (6 C,
2 tBu), 32.0 (C9Ј), 34.8 (C5), 37.2 (C8), 37.6 (C7Ј), 38.2 (C6), 39.4
(C1Ј), 43.4 (C4), 45.3 (C5Ј), 67.9 (C6Ј), 68.9 (2 C, C9, C8Ј), 69.5
(C7), 73.5 (C2Ј), 73.7 (tBu), 73.8 (tBuЈ), 74.3 (C1), 170.5 (Ac), 170.6
8-tert-Butoxy-6-(tert-butyldimethylsilanyloxy)-1-methyl-4-oxo-3-
oxabicyclo[2.2.2]non-2-yl Acetate (21a): Starting from 15a (37 mg,
0.09 mmol) and using the general procedure, 21a (21.5 mg, 56%)
was obtained, after stirring at room temp. for 25 h (silica gel
chromatography, heptane/EtOAc, 20:1 to 10:1), along with unre-
acted starting material 15a (9.6 mg, 26%). [α]2D0 = +13 (c = 0.7,
CHCl3). M.p. 146–147 °C (CH2Cl2). 1H NMR (300 MHz, CDCl3):
δ = 0.00 (2 s, 6 H), 0.81 (s, 9 H), 0.98 (s, 3 H), 1.09 (s, 9 H), 1.79
(m, 2 H), 2.02 (s, 3 H), 2.04–2.20 (m, 2 H), 2.97 (m, 1 H), 3.38 (t,
J = 8.0 Hz, 1 H), 3.99 (m, 1 H), 6.13 (s, 1 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = –4.9, –4.8, 17.9, 20.9, 24.6, 25.6 (3 C), 28.8
(3 C), 31.3, 41.6, 43.6, 49.3, 65.6, 70.1, 73.3, 97.9, 169.1, 172.2 ppm.
IR (film): ν = 2960, 2858, 1752, 1363, 1016 cm–1. ESIMS (MeOH):
˜
m/z (%) = 437.2 (100) [M + Na]+. HRESIMS: calcd. for C21H38O6-
SiNa 437.2335; found 437.2328. C21H38O6Si (414.24): calcd. C
60.83, H 9.24; found C 60.69, H 9.24.
8-tert-Butoxy-6-(tert-butyldimethylsilanyloxy)-1-methyl-4-oxo-3-
oxabicyclo[3.2.2]non-2-yl Acetate (21b): Starting from 15b (110 mg,
0.27 mmol) and using the general procedure, 21b (106 mg, 95%)
was obtained, after stirring at room temp. for 2 h as a single prod-
uct (silica gel chromatography, heptane/EtOAc, 20:1 to 10:1). [α]2D0
= +100 (c = 1.2, CHCl3). M.p. 94–96 °C (CH2Cl2). 1H NMR
(300 MHz, CDCl3): δ = 0.07 (2 s, 6 H), 0.89 (s, 9 H), 0.99 (s, 3 H),
1.17 (s, 9 H), 1.66 (dd, J = 8.6, 15.2 Hz, 1 H), 1.89 (dt, J = 3.0,
15.4 Hz, 1 H), 1.97–2.09 (m, 2 H), 2.10 (s, 3 H), 3.06 (m, 1 H), 3.51
(dd, J = 3.5, 8.7 Hz, 1 H), 3.97 (m, 1 H), 6.42 (s, 1 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = –4.9 (2 C), 17.9, 21.0, 24.9, 25.6 (3
C), 28.7 (3 C), 32.2, 37.5, 42.3, 48.9, 66.0, 70.3, 74.0, 94.7, 169.1,
(Ac), 172.3 (C3), 173.0 (C4Ј) ppm. IR (film): ν = 2975, 1738, 1731,
˜
1366, 1242, 1049 cm–1. ESIMS (MeOH): m/z (%) = 307.1 (100)
[M + Na]+. HRESIMS: calcd. for C15H24O5Na 307.1521; found
307.1505. C15H24O5 (284.16): calcd. C 63.36, H 8.51; found C
63.61, H 8.45
6-tert-Butoxy-8-hydroxy-5-methyl-2-oxabicyclo[3.2.2]nonan-3-one
(26) and 6-tert-Butoxy-8-hydroxy-5-methyl-3-oxabicyclo[3.2.2]-
nonan-2-one (27): Starting from 17a (40 mg, 0.17 mmol) and using
the general procedure bridgehead migrated 26 (17.2 mg) and meth-
ylene migrated 27 (18.8 mg) were obtained in 88% combined yield
and 1:1.1 ratio after stirring at room temp. for 4 h (silica gel
171.5 ppm. IR (film): ν = 2930, 2857, 1749, 1225, 1173 cm–1. ES-
˜
IMS (MeOH): m/z (%) = 437.2 (100) [M + Na]+, 453.2 (12) [M +
K]+. HRESIMS: calcd. for C21H38O6NaSi 437.2335; found
437.2339. C21H38O6Si (414.24): calcd. C 60.83, H 9.24; found C
60.59, H 9.17.
chromatography, heptane/EtOAc, 2:1 to 1.5:1). Data for 26: [α]2D0
=
+28 (c = 0.8, CHCl3). M.p. 86–88 °C (heptane). 1H NMR
9-tert-Butoxy-5-methyl-3-oxo-2-oxabicyclo[3.2.2]non-7-yl Toluene- (300 MHz, CDCl3): δ = 0.95 (s, 3 H), 1.18 (s, 9 H), 1.45 (ddd, J =
4-sulfonate (23), 8-tert-Butoxy-1-methyl-4-oxo-3-oxabicy- 2.4, 5.0, 14.7 Hz, 1 H), 2.03 (m, 1 H), 2.18 (dd, J = 8.1, 14.7 Hz, 1
clo[3.2.2]non-6-yl Toluene-4-sulfonate (22): Starting from 10 (49 mg, H), 2.31 (dd, J = 1.1, 18.5 Hz, 1 H), 2.48 (ddd, J = 4.3, 8.5, 15.8 Hz,
0.12 mmol) and using the general procedure, 22 and 23 (11.5 mg)
were obtained as an inseparable mixture, after stirring at room
temp. for 4 d in 24 % combined yield and 1:1.5 ratio (silica gel
chromatography, heptane/EtOAc, 10:1 to 3:1), along with unre-
acted starting material 10 (33.8 mg, 69%). 1H NMR (300 MHz,
1 H), 3.01 (dd, J = 2.5, 18.5 Hz, 1 H), 3.64 (dd, J = 2.9, 8.5 Hz, 1
H), 4.29 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 27.9, 28.8
(3 C), 34.4, 34.5, 42.0, 43.3, 67.1, 70.5, 73.7, 78.0, 173.9 ppm. IR
(film): ν = 3394, 2975, 2929, 1708, 1390, 1067 cm–1. ESIMS
˜
(MeOH): m/z (%) = 243.2 (100) [M + H]+, 265.2 (14) [M + Na]+,
CDCl3): δ = 0.89 (s, 3 H, MeЈ), 0.90 (s, 3 H, Me), 1.10 (s, 18 H, 281.1 (8) [M + K]+. HRESIMS: calcd. for C13H22O4Na m/z
Eur. J. Org. Chem. 2007, 4116–4123
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4121